Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B lymphocytes protect islet β cells in diabetes-prone NOD mice treated with imatinib
Christopher Wilson, Jason M. Spaeth, Jay Karp, et al.
JCI Insight (2019) Vol. 4, Iss. 9
Open Access | Times Cited: 13

Showing 13 citing articles:

TCL1A in naïve B cells as a therapeutic target for type 1 diabetes
Siweier Luo, Lína Zhang, Chunfang Wei, et al.
EBioMedicine (2025) Vol. 113, pp. 105593-105593
Closed Access | Times Cited: 1
Decoding inflammation, its causes, genomic responses, and emerging countermeasures
Jacek Hawiger, J Zienkiewicz
Scandinavian Journal of Immunology (2019) Vol. 90, Iss. 6
Open Access | Times Cited: 57
An accomplice more than a mere victim: The impact of β-cell ER stress on type 1 diabetes pathogenesis
Gulcan Semra Sahin, Hugo Lee, Feyza Engin
Molecular Metabolism (2021) Vol. 54, pp. 101365-101365
Open Access | Times Cited: 52
Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside
Gabriel Brawerman, Peter J. Thompson
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1681-1681
Open Access | Times Cited: 22
NLRP6 deficiency expands a novel CD103+ B cell population that confers immune tolerance in NOD mice
James A. Pearson, Jian Peng, Juan Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
B Cell Metabolism: An Understudied Opportunity to Improve Immune Therapy in Autoimmune Type 1 Diabetes
Christopher Wilson, Daniel J. Moore
Immunometabolism (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 11
Tyrosine Kinase Targeting
Mohammad Althubiti
Saudi Journal of Medicine and Medical Sciences (2022) Vol. 10, Iss. 3, pp. 183-191
Open Access | Times Cited: 7
Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases
Ming Yang, Ping Yi, Jiao Jiang, et al.
International Reviews of Immunology (2021) Vol. 42, Iss. 1, pp. 1-25
Closed Access | Times Cited: 7
Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK
Andris Elksnis, Tomas A. Schiffer, Fredrik Palm, et al.
Clinical Science (2021) Vol. 135, Iss. 19, pp. 2243-2263
Open Access | Times Cited: 7
The protective effect of imatinib against pancreatic β-cell apoptosis induced by dexamethasone via increased GSTP1 expression and reduced oxidative stress
Namoiy Semprasert, Petcharee Maneethorn, Suwattanee Kooptiwut
Research Square (Research Square) (2024)
Open Access
The protective effect of imatinib against pancreatic β-cell apoptosis induced by dexamethasone via increased GSTP1 expression and reduced oxidative stress
Namoiy Semprasert, Petcharee Maneethorn, Suwattanee Kooptiwut
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice
Kazuhisa Kishi, Tomohiro Yonezawa, Noriyuki Kaji, et al.
Journal of Veterinary Medical Science (2023) Vol. 85, Iss. 7, pp. 781-789
Open Access | Times Cited: 1
Are off-target effects of imatinib the key to improving beta-cell function in diabetes?
Nils Welsh
Upsala Journal of Medical Sciences (2022) Vol. 127
Open Access | Times Cited: 1
Page 1

Scroll to top